Loading...
Loading...
Oculus Innovative Sciences, Inc.
OCLS gained 2.3% to $1.80 following the Monday's FDA 510(K) clearance for Alevicyn SG Antipruritic Spray Gel. Share volume was 1.3 million, towering over an all-day average of 89,000
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in